One of the most amazing accomplishments of Byzantine monasteries was the miraculous preservation of ancient Greek treasures ...

We recently published 10 Stocks Lighting Up Market Ahead of Christmas. Agios Pharmaceuticals, Inc. (NASDAQ:AGIO) is one of the best performers on Wednesday. Agios Pharmaceuticals soared by 18.63 ...

Agios Pharmaceuticals (AGIO) shares ended the last trading session 18.6% higher at $29.17. The jump came on an impressive volume with a higher-than-average number of shares changing hands in the ...

Ancient Greeks knew a thing or two when it came to herbs, and oregano is one that they simply could not do without.

The U.S. Food and Drug Administration (FDA) on Tuesday approved Agios Pharmaceuticals, Inc.’s (NASDAQ: AGIO) Aqvesme (mitapivat), an oral pyruvate kinase (PK) activator, for anemia in adults with ...

CAMBRIDGE, Mass. - The U.S. Food and Drug Administration has approved AQVESME (mitapivat), an oral pyruvate kinase activator, for the treatment of anemia in adults with alpha- or beta-thalassemia, ...

The new indication is relatively rare in the U.S., but pricing is substantial, and the need for the treatment is significant. The positive update turns the company's fortunes around after a ...

Servier looks like it could bring a second IDH inhibitor from its 2021 takeover of Agios’ oncology business to market, after reporting positive results in a phase 3 brain cancer trial. The drug ...

・BofA raised AGIO’s price target to $34 from $32, while maintaining a ‘Buy’ rating, according to The Fly. ・The approval is based on results from the global Phase 3 ENERGIZE and ENERGIZE-T trials, ...

If you want a vacation at the beach, late May to early October is the best time to visit Greece, according to Sarmantas and Ramanathan of Curated Greece: “The water is warmest from July to September, ...